23:56 , Aug 2, 2017 |  BC Extra  |  Company News

Management tracks: Grail, Foresee, Applied Genetic Technologies

Cancer company Grail Inc. (Menlo Park, Calif.) named Chairman Bill Rastetter as CEO. The company also promoted Ken Drazen to president from CBO. Drug delivery company Foresee Pharmaceuticals Co. Ltd. (TPEx-E:6576) named Lawrence Gan CEO....
17:38 , Mar 30, 2017 |  BC Innovations  |  Distillery Therapeutics

Cancer

INDICATION: Breast cancer Patient sample and mouse studies suggest aldose reductase inhibitors could help treat metastatic basal-like breast cancer. In metastatic breast cancer patients, levels of aldose reductase were higher in primary tumors from patients...
07:00 , May 23, 2016 |  BC Week In Review  |  Clinical News

Diepalrestat choline: Completed Phase IIb enrollment

BioNevia and NeuroMax completed enrollment of 400 patients in the double-blind, placebo-controlled, Russian Phase IIb NM-ARI-231 trial evaluating oral BNV-222 for 1 year. BioNevia and NeuroMax are developing BNV-222. NeuroMax Ltd. , Moscow, Russia  ...